DE3788229D1 - Verfahren zur isolierung von ca 125-antigen. - Google Patents

Verfahren zur isolierung von ca 125-antigen.

Info

Publication number
DE3788229D1
DE3788229D1 DE87908082T DE3788229T DE3788229D1 DE 3788229 D1 DE3788229 D1 DE 3788229D1 DE 87908082 T DE87908082 T DE 87908082T DE 3788229 T DE3788229 T DE 3788229T DE 3788229 D1 DE3788229 D1 DE 3788229D1
Authority
DE
Germany
Prior art keywords
antigen
antiges
insulating
isolated
glycoprotein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE87908082T
Other languages
English (en)
Other versions
DE3788229T2 (de
DE3788229T3 (de
Inventor
Hugh Davis
Thomas Klug
Vincent Zurawski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Biotech Inc
Original Assignee
Centocor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25464497&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3788229(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Centocor Inc filed Critical Centocor Inc
Application granted granted Critical
Publication of DE3788229D1 publication Critical patent/DE3788229D1/de
Publication of DE3788229T2 publication Critical patent/DE3788229T2/de
Publication of DE3788229T3 publication Critical patent/DE3788229T3/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/832—Milk; colostrum
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/85—Reproductive organs or embryos
    • Y10S530/852—Sperm
    • Y10S530/853—Ovary; eggs; embryos

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Heads (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
DE3788229T 1986-11-24 1987-11-20 Verfahren zur isolierung von ca 125-antigen. Expired - Lifetime DE3788229T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/933,784 US5059680A (en) 1986-11-24 1986-11-24 Method of isolating ca 125 antigen
PCT/US1987/003052 WO1988003954A1 (en) 1986-11-24 1987-11-20 Method of isolating ca 125 antigen

Publications (3)

Publication Number Publication Date
DE3788229D1 true DE3788229D1 (de) 1993-12-23
DE3788229T2 DE3788229T2 (de) 1994-04-21
DE3788229T3 DE3788229T3 (de) 1997-04-10

Family

ID=25464497

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3788229T Expired - Lifetime DE3788229T3 (de) 1986-11-24 1987-11-20 Verfahren zur isolierung von ca 125-antigen.

Country Status (7)

Country Link
US (1) US5059680A (de)
EP (1) EP0332651B2 (de)
JP (1) JPH02501258A (de)
AT (1) ATE97448T1 (de)
CA (1) CA1305416C (de)
DE (1) DE3788229T3 (de)
WO (1) WO1988003954A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5366866A (en) * 1991-07-25 1994-11-22 Duke University Method of diagnosing ovarian and endometrial cancer with monoclonal antibodies OXA and OXB
US5976818A (en) * 1991-12-16 1999-11-02 The Board Of Trustees Of The University Of Arkansas Monoclonal antibodies which identify the glycoprotein carrying the CA 125 epitope
WO1997009925A2 (en) * 1995-09-12 1997-03-20 The General Hospital Corporation Method for early detection of ovarian cancer
US5800347A (en) * 1995-11-03 1998-09-01 The General Hospital Corporation ROC method for early detection of disease
US7318921B2 (en) 1996-05-15 2008-01-15 Altarex Medical Corp. Therapeutic compositions that alter the immune response
US8038994B2 (en) 1996-05-15 2011-10-18 Quest Pharmatech Inc. Combination therapy for treating disease
IL139700A (en) 1998-06-15 2005-09-25 Altarex Medical Corp Immunotherapeutic composition for the treatment of prostate cancer
US6376654B1 (en) 1999-08-13 2002-04-23 Molecular Discoveries, Llc Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof
US7226750B1 (en) 2000-08-08 2007-06-05 Molecular Discoveries, Inc. Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof
WO2002020620A2 (en) * 2000-09-05 2002-03-14 Medical Research Council Monoclonal antibody against ovarian carcinoma
PT2301965E (pt) 2002-10-16 2015-05-20 Purdue Pharma Lp Anticorpos que se ligam a ca 125/0722p associado a células e métodos para a sua utilização
EP2302390B1 (de) * 2003-07-15 2013-06-05 The Regents of The University of California Verfahren zur Detektion und Analyse von N-Glykolylneuraminsäure (Neu5Gc) spezifischen Antikörpern in biologischen Materialien
WO2013151649A1 (en) 2012-04-04 2013-10-10 Sialix Inc Glycan-interacting compounds
US9879087B2 (en) 2014-11-12 2018-01-30 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
CA2967595A1 (en) 2014-11-12 2016-05-19 Siamab Therapeutics, Inc. Glycan-interacting compounds and methods of use
MX2018005061A (es) 2015-11-12 2019-02-28 Siamab Therapeutics Inc Compuestos de interacción con glicanos y métodos de uso.
US11401330B2 (en) 2016-11-17 2022-08-02 Seagen Inc. Glycan-interacting compounds and methods of use
CN110913903B (zh) 2017-03-03 2024-03-01 思进股份有限公司 聚糖相互作用化合物和使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2630380A1 (de) * 1975-07-14 1977-02-03 Microlog Ltd Verfahren zur herstellung einer vakzine
US4584278A (en) * 1982-03-19 1986-04-22 University Of Rochester Antigen derived from human ovarian tumors and radioimmunoassay using the antigen
JPS60256284A (ja) * 1984-06-01 1985-12-17 Nippon Telegr & Teleph Corp <Ntt> 動画像送受信方式

Also Published As

Publication number Publication date
JPH02501258A (ja) 1990-05-10
CA1305416C (en) 1992-07-21
DE3788229T2 (de) 1994-04-21
EP0332651A1 (de) 1989-09-20
DE3788229T3 (de) 1997-04-10
US5059680A (en) 1991-10-22
EP0332651B1 (de) 1993-11-18
WO1988003954A1 (en) 1988-06-02
ATE97448T1 (de) 1993-12-15
EP0332651B2 (de) 1996-12-27

Similar Documents

Publication Publication Date Title
DE3788229D1 (de) Verfahren zur isolierung von ca 125-antigen.
DE3781133D1 (de) Herstellung von polymilchsaeure und copolymeren daraus.
DE3789203T2 (de) Verfahren zur Herstellung von modifizierten Kautschuk-Dienpolymeren.
IT1164626B (it) Procedimento per il ricupero di ifn-b umano da microorganismi produttori trasformati
DE3587617T2 (de) Verfahren zur herstellung von bipolaren halbleiteranordnungen.
FI852522L (fi) Menetelmä tymopentiinianalogien valmistamiseksi
DE3689067T2 (de) Verfahren zur herstellung von optischen halbleiterstrukturen.
ES2068404T3 (es) Un metodo para aislar el factor viii.
ATE60583T1 (de) Verfahren zur herstellung von 2,2,6,6-tetraalkyl- 4-piperidylaminen.
DE3751018D1 (de) Verfahren zur Herstellung von direkt-positiven Bildern.
DE58901324D1 (de) Verfahren zur herstellung von solarsilicium.
DE59008005D1 (de) Verfahren zur Herstellung von hochmolekularen Copolyarylensulfiden.
DE3587839T2 (de) Verfahren zur Herstellung von L-Phenylalanin.
DE3780527T2 (de) Verfahren zur herstellung von 5&#39;-guanyl-saeure.
DE3675855D1 (de) Verfahren zur herstellung von hochmolekularen, gegebenenfalls verzweigten polyarylensulfiden.
DE3574868D1 (de) Verfahren zur herstellung von unsymmetrischen diestern von 1,4-dihydropyridin-3,5-dicarbonsaeure.
DE3677401D1 (de) Verfahren zur herstellung von perylen-3,4,9,10-tetracarbonsaeurearylimiden.
ES546528A0 (es) Procedimiento para aislar un polipeptido preparado de forma recombinante,a partir de celulas bacterianas
DE3768426D1 (de) Verfahren zur herstellung von 4,4&#39;-biphenyldicarbonsaeure.
ATE82578T1 (de) Verfahren zur herstellung von farbstabiler methylglucose von technischer qualitaet.
DE3764492D1 (de) Verfahren zur herstellung von als adjuvans fuer detergentien verwendbaren oxodisuccinaten.
DE3762619D1 (de) Verfahren zur herstellung monomerer alpha-cyanacrylate.
DE58901794D1 (de) Verfahren zur herstellung von tert.-olefinen.
DE3786892D1 (de) Verfahren zur herstellung von organosiliconpolymeren.
DE3578417D1 (de) Verfahren zur herstellung von alpha-arylalkansaeuren.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8366 Restricted maintained after opposition proceedings